92,391 Waters Corporation $WAT Shares Sold by Allspring Global Investments Holdings LLC

Key Points

• Allspring Global Investments cut its Waters stake by 11.9%, selling 92,391 shares in the third quarter; it retained 682,445 shares valued at about $290.4 million.
• Other institutional investors adjusted their positions, while hedge funds and institutions collectively own about 94% of Waters’ stock.
• Waters beat quarterly earnings and revenue estimates, reporting $4.10 per share and $1.77 billion in revenue. Analysts’ consensus rating was “Moderate Buy,” with an average price target of $475.48.

Allspring Global Investments Holdings LLC trimmed its holdings in shares of Waters Corporation (NYSE:WAT - Free Report) by 11.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 682,445 shares of the medical instruments supplier's stock after selling 92,391 shares during the period. Allspring Global Investments Holdings LLC owned approximately 0.69% of Waters worth $290,401,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. StoneRidge PMG Advisors LLC purchased a new stake in shares of Waters in the 3rd quarter worth approximately $485,000. Hohimer Wealth Management LLC purchased a new position in Waters during the third quarter valued at $589,000. Candriam S.C.A. raised its stake in Waters by 21.2% during the third quarter. Candriam S.C.A. now owns 31,187 shares of the medical instruments supplier's stock valued at $13,753,000 after buying an additional 5,462 shares during the last quarter. Ethic Inc. raised its stake in Waters by 7.2% during the third quarter. Ethic Inc. now owns 11,375 shares of the medical instruments supplier's stock valued at $4,998,000 after buying an additional 767 shares during the last quarter. Finally, Calamos Wealth Management LLC bought a new stake in Waters in the third quarter worth $8,715,000. 94.01% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on WAT. KeyCorp increased their target price on Waters from $460.00 to $500.00 and gave the stock an "overweight" rating in a research note on Wednesday, November 4th. Barclays lifted their price target on Waters from $500.00 to $530.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 4th. Piper Sandler raised Waters from a "neutral" rating to an "overweight" rating and lifted their price target for the stock from $400.00 to $480.00 in a research report on Thursday, August 27th. Royal Bank Of Canada upped their price target on shares of Waters from $475.00 to $525.00 and gave the stock an "outperform" rating in a research note on Wednesday, November 4th. Finally, Jefferies Financial Group increased their price objective on shares of Waters from $450.00 to $455.00 and gave the company a "buy" rating in a research report on Wednesday, August 5th. One analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $475.48.

Trending Headlines about Waters

Here are the key news stories impacting Waters this week:

• Positive Sentiment: Waters reported $1.77 billion in third-quarter 2026 revenue and raised its full-year guidance, signaling improved expectations for the business. Waters Corporation Reports $1.77 Billion in Third Quarter 2026 Revenue and Raises Full-Year Guidance
• Positive Sentiment: The company agreed to acquire MOBILion Systems, expanding its mass spectrometry and AI-powered proteomics capabilities. The strategic fit could broaden Waters’ technology offering, though the reported item does not quantify the deal’s financial impact. Waters Corporation Acquires MOBILion Systems
• Positive Sentiment: JPMorgan, Barclays, KeyCorp, TD Cowen, Citigroup, and RBC issued reports indicating higher price targets or strong potential appreciation, reinforcing a favorable analyst outlook. JPMorgan price target Barclays outlook KeyCorp outlook TD Cowen price target Citigroup price target RBC outlook

Waters Trading Up 0.1%

Waters stock opened at $457.92 on Monday. The company has a debt-to-equity ratio of 0.32, a current ratio of 0.66 and a quick ratio of 0.40. Waters Corporation has a one year low of $282.77 and a one year high of $482.28. The stock has a market capitalization of $44.99 billion, a PE ratio of 196.53, a price-to-earnings-growth ratio of 2.60 and a beta of 1.16. The business's fifty day moving average is $434.72 and its 200 day moving average is $372.24.

Waters (NYSE:WAT - Get Free Report) last issued its earnings results on Tuesday, November 3rd. The medical instruments supplier reported $4.10 earnings per share for the quarter, topping analysts' consensus estimates of $4.00 by $0.10. The business had revenue of $1.77 billion during the quarter, compared to analyst estimates of $1.75 billion. Waters had a return on equity of 9.91% and a net margin of 1.75%. Waters's revenue was up 120.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.40 EPS. On average, sell-side analysts predict that Waters Corporation will post 14.65 EPS for the current year.

Waters Company Profile

Waters Corporation develops and supplies analytical instruments, software, and consumables used to identify, measure, and characterize chemical and biological materials. Its products include liquid chromatography and mass spectrometry systems, which help customers analyze complex samples.

The company serves pharmaceutical and biotechnology businesses, academic and government laboratories, and customers in fields such as food, environmental testing, and materials science. Waters operates internationally, with customers and operations across multiple regions.

Founded in 1958 by James L.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.